Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
494
NCT02700776
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
Phase: N/A
Role: Collaborator
Start: Apr 30, 2014
Completion: Feb 27, 2017
NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 14, 2022
Completion: Nov 30, 2026